J0695 – Injection, ceftolozane 50 mg and tazobactam 25 mg

Long description

Injection, ceftolozane 50 mg and tazobactam 25 mg

Short description

Inj ceftolozane tazobactam

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

January 1, 2016

Last change

January 1, 2016 – No change

Nearby J codes

• J0687 – Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
• J0688 – Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
• J0689 – Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
• J0690 – Injection, cefazolin sodium, 500 mg
• J0691 – Injection, lefamulin, 1 mg
• J0692 – Injection, cefepime hydrochloride, 500 mg
• J0693 – Injection, cefiderocol, 5 mg
• J0694 – Injection, cefoxitin sodium, 1 gm
• J0696 – Injection, ceftriaxone sodium, per 250 mg
• J0697 – Injection, sterile cefuroxime sodium, per 750 mg
• J0698 – Injection, cefotaxime sodium, per gm
• J0699 – Injection, cefiderocol, 10 mg
• J0701 – Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
• J0702 – Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
• J0703 – Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
• J0706 – Injection, caffeine citrate, 5 mg